Beta Bionics, Inc. (BBNX) Profit Margins
Over the twelve months to 2026-06-30, Beta Bionics, Inc. (BBNX) had gross margin 58.3%, operating margin -69.8%, net margin -61.3%, free cash flow margin -51.6%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BBNXBeta Bionics, Inc.Follow BBNX — free
—
Price chart with a free account
- Market cap
- 862.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 2 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Gross margin | 55.1% | 55.4% | 58.3% | |
| Operating margin | -69.5% | -71.5% | -69.8% | |
| Net margin | -84.1% | -73.0% | -61.3% | |
| FCF margin | -79.3% | -56.1% | -51.6% |
USD millions · SEC XBRL
Beta Bionics, Inc. — questions
- What is Beta Bionics, Inc.'s gross margin?
- 58.3% over the twelve months to 2026-06-30.
- What is Beta Bionics, Inc.'s operating margin?
- -69.8% over the twelve months to 2026-06-30.
- What is Beta Bionics, Inc.'s net profit margin?
- -61.3% over the twelve months to 2026-06-30.
Every figure on this page comes from Beta Bionics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.